Aum Biotech, LLC

Carisma Therapeutics Inc. is a Philadelphia-based biotech company that is revolutionizing cancer treatment through the development of CAR-Macrophages, a groundbreaking approach to immunotherapy. By engineering monocytes and macrophages to attack tumors, Carisma's innovative cellular therapies have the potential to deliver long-term anti-tumor immunity and significantly improve patient outcomes. With a focus on leveraging advances in macrophage biology, chimeric antigen receptor engineering, and adoptive cellular therapy, Carisma's unique therapeutic approach engages both the innate and adaptive immune systems to launch a multi-pronged attack on tumors. By addressing key challenges faced by current cell therapies, such as tumor infiltration, immunosuppressive tumor microenvironments, and antigen heterogeneity, Carisma is at the forefront of developing life-changing treatments for patients with cancer and other serious disorders.Generated from the website

Mebias Discovery is a Philadelphia-based company specializing in innovative drug discovery and development, with a focus on G Protein Coupled Receptors (GPCRs). Their proprietary membrane protein-NMR drug discovery platform enables the identification of highly selective molecules that bind to GPCR targets, eliminating adverse effects and maximizing therapeutic potential. With seven years of experience, Mebias Discovery has successfully validated their unique drug discovery platform and identified an FDA-approved Investigational New Drug for the mu-opioid receptor. Additionally, they are currently developing Sphingosine 1-phosphate receptor agonists for the treatment of neuropathic pain.Generated from the website

Integral Molecular, located in Philadelphia, PA, is a leading biotechnology company specializing in membrane proteome arrays, virology reagents and services, lipoparticles, virus-like particles (VLPs), antibody discovery, epitope mapping, and protein engineering. The company offers cutting-edge technologies for research and development, with a focus on advancing scientific discoveries in the fields of molecular biology, virology, and antibody therapeutics. Generated from the website